FOXNews.com: New blood test for detecting ovarian cancer shows positive result

FOXNews.com FOX News Network - We Report. You Decide. // via fulltextrssfeed.com

New blood test for detecting ovarian cancer shows positive result Jul 30th 2012, 15:12 Diagnostics company Vermillion Inc said a clinical trial of its blood test for detecting ovarian cancer showed the test had a high chance of correctly identifying patients with cancer. Shares of the company jumped 21 percent to $2.17 on the news. The study, named OVA1, is a blood test for pre-surgical assessment of ovarian tumors for malignancy. The study focused on two particularly challenging subgroups - women with early-stage ovarian cancer and pre-menopausal women. "A key goal of the study was to investigate the challenging pre-menopausal setting, where benign cysts have a high incidence and early-stage cancer often goes undetected," Chief Executive Gail Page said. The test had a 94 percent sensitivity in the pre-menopausal group, and a 91 percent sensitivity in the early-stage ovarian cancer group. A diagnostic test's sensitivity refers to its ability to correctly identify those who are actually affected by the disease. Overall, the test showed a 96 percent sensitivity. OVA1 also had a low chance of mistakenly classifying a sick person as healthy. Vermillion shares were up 11 percent at $2 in morning trade on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions